Sedoxantrone
Alternative Names: CI 958; NSC 635371; PD 114595; PD 121373; Sedoxantrone trihydrochlorideLatest Information Update: 24 Oct 2003
At a glance
- Originator Pfizer
- Class
- Mechanism of Action DNA helicase inhibitors; DNA inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Colorectal cancer; Prostate cancer; Solid tumours
Most Recent Events
- 24 Oct 2003 No development reported - Phase-II for Colorectal cancer in USA (IV)
- 24 Oct 2003 No development reported - Phase-II for Prostate cancer in USA (IV-infusion)
- 24 Oct 2003 No development reported - Phase-II for Solid tumours in USA (IV)